These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38099369)

  • 1. Factors affecting adherence to glaucoma medication: Patient perspective from North India.
    Singh K; Singh A; Jain D; Verma V
    Indian J Ophthalmol; 2024 Mar; 72(3):391-396. PubMed ID: 38099369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucoma severity and medication adherence in a county hospital population.
    Ung C; Zhang E; Alfaro T; Murakami Y; Zhang M; Seider MI; Lin SC; Singh K
    Ophthalmology; 2013 Jun; 120(6):1150-7. PubMed ID: 23453512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia.
    Mehari T; Giorgis AT; Shibeshi W
    BMC Ophthalmol; 2016 Aug; 16():131. PubMed ID: 27485739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of medication adherence to topical glaucoma therapy.
    Dreer LE; Girkin C; Mansberger SL
    J Glaucoma; 2012; 21(4):234-40. PubMed ID: 21623223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
    Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
    Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan.
    Tsumura T; Kashiwagi K; Suzuki Y; Yoshikawa K; Suzumura H; Maeda T; Takeda R; Saito H; Araie M
    Int Ophthalmol; 2019 Feb; 39(2):375-383. PubMed ID: 29330811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to topical glaucoma medications in Ethiopian patients.
    Tamrat L; Gessesse GW; Gelaw Y
    Middle East Afr J Ophthalmol; 2015; 22(1):59-63. PubMed ID: 25624675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of an Educational Intervention on Adherence to Intraocular Pressure-Lowering Medications in a Large Cohort of Older Adults with Glaucoma.
    Fiscella R; Caplan E; Kamble P; Bunniran S; Uribe C; Chandwani H
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1284-1294. PubMed ID: 29848186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between quality of life and adherence to medication in glaucoma patients in Singapore.
    Loon SC; Jin J; Jin Goh M
    J Glaucoma; 2015; 24(5):e36-42. PubMed ID: 24248002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of medication adherence of glaucoma patients during the COVID-19 pandemic.
    Fırat PG; Dikci S; Can A; Türkoğlu EB
    J Fr Ophtalmol; 2023 Jan; 46(1):11-18. PubMed ID: 36435659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Patient Education and Telemedicine Reminders on Adherence to Eye Drops for Glaucoma.
    Lai Y; Wu Y; Chai C; Yen CC; Ho Y; Eng TC; Jain P; Koh V
    Ophthalmol Glaucoma; 2020; 3(5):369-376. PubMed ID: 32980041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Maccabi Glaucoma Study: Treatment Patterns and Persistence With Glaucoma Therapy in a Large Israeli Health Maintenance Organization.
    Goldshtein I; Shalev V; Zigman N; Chodick G; Levkovitch-Verbin H
    J Glaucoma; 2016 Apr; 25(4):e386-91. PubMed ID: 26900826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of glaucoma medication adherence monitoring in the digital health era.
    Erras A; Shahrvini B; Weinreb RN; Baxter SL
    Br J Ophthalmol; 2023 Feb; 107(2):153-159. PubMed ID: 33858837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.
    Park MH; Kang KD; Moon J;
    Jpn J Ophthalmol; 2013 Jan; 57(1):47-56. PubMed ID: 23065047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to topical glaucoma medications and associated factors in Gondar University Hospital Tertiary Eye Care Center, northwest Ethiopia.
    Anbesse DH; Yibekal BT; Assefa NL
    Eur J Ophthalmol; 2019 Mar; 29(2):189-195. PubMed ID: 29747522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Text Parsing-Based Identification of Patients with Poor Glaucoma Medication Adherence in the Electronic Health Record.
    Hamid MS; Valicevic A; Brenneman B; Niziol LM; Stein JD; Newman-Casey PA
    Am J Ophthalmol; 2021 Feb; 222():54-59. PubMed ID: 32926847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.
    Zhang L; Weizer JS; Musch DC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD010746. PubMed ID: 28231380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the number of glaucoma medications, ocular surface disorder, and treatment adherence.
    Samico GA; Abe RY; Prata TS; Teixeira SH; Paranhos A; Gracitelli CPB
    Arq Bras Oftalmol; 2023; 87(6):e20210525. PubMed ID: 37851737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attributes Associated with Adherence to Glaucoma Medical Therapy and its Effects on Glaucoma Outcomes: An Evidence-Based Review and Potential Strategies to Improve Adherence.
    Joseph A; Pasquale LR
    Semin Ophthalmol; 2017; 32(1):86-90. PubMed ID: 27792450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.